Results

2 stories for“surmount-1 trial”

Mounjaro and Zepbound: The Case for Two Hormones at Once

Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.

Dec 9, 2024

Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.

Jan 8, 2025